Legend Biotech Corporation (LEGN)

Legend Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Jan 1, 2020
Cash & Equivalents	459.28	1,278	786.03	688.94	455.69	83.36
Short-Term Investments	753.12	30.34	54.02	193.46	50	75.56
Trading Asset Securities	-	0.66	185.6	-	-	-
Cash & Short-Term Investments	1,212	1,309	1,026	882.4	505.69	158.92
Cash Growth	-14.85%	27.60%	16.23%	74.49%	218.20%	-26.49%
Accounts Receivable	0.87	101.43	0.28	50.5	75.62	30
Other Receivables	103.11	55.63	44.24	8.04	7	-
Receivables	103.98	157.06	44.52	58.55	82.62	30
Inventory	23.55	19.43	10.35	1.75	1.8	1.16
Prepaid Expenses	9.53	12.23	17.33	5.72	3.46	21.67
Other Current Assets	0.58	0.36	1.27	1.44	0.38	0.26
Total Current Assets	1,350	1,498	1,099	949.85	593.94	212.01
Property, Plant & Equipment	203.48	189.23	160.76	140.79	111.88	72.98
Long-Term Investments	4.51	4.36	-	4.71	-	-
Other Intangible Assets	2.51	4.06	3.41	4.68	2.85	0.52
Long-Term Accounts Receivable	-	0.29	0.4	-	-	-
Other Long-Term Assets	175.29	152.88	67.28	19.44	13.41	7.11
Total Assets	1,736	1,849	1,331	1,119	722.09	292.62
Accounts Payable	26.91	20.16	32.89	7.04	4.91	9.59
Accrued Expenses	141.22	105.41	152.73	104.38	74.36	-
Short-Term Debt	-	-	-	-	0.33	-
Current Portion of Leases	4.34	3.18	3.56	0.91	1.46	1.03
Current Income Taxes Payable	11.07	7.2	9.77	9.49	8.8	12.78
Current Unearned Revenue	63.72	53.08	0.45	0.3	0.28	-
Other Current Liabilities	23.64	27.39	98.38	107.08	25.42	70.85
Total Current Liabilities	270.89	216.42	297.79	229.2	115.57	94.25
Long-Term Debt	296.62	281.33	260.93	120.46	-	-
Long-Term Leases	45.63	44.17	20.04	1.59	1.91	5.06
Long-Term Unearned Revenue	6.55	55.27	7.66	1.87	2.05	-
Long-Term Deferred Tax Liabilities	-	-	-	-	4.24	41.99
Other Long-Term Liabilities	0.03	0.06	0.23	0.4	0.55	-
Total Liabilities	619.72	597.24	586.65	353.52	124.32	141.3
Common Stock	0.04	0.04	0.03	0.03	0.03	0.02
Additional Paid-In Capital	2,686	2,637	1,657	1,261	708.31	3.91
Retained Earnings	-1,688	-1,485	-966.46	-520.11	-116.53	149.85
Comprehensive Income & Other	118.36	98.93	53.72	24.57	5.96	-2.45
Shareholders' Equity	1,116	1,251	744.31	765.94	597.77	151.32
Total Liabilities & Equity	1,736	1,849	1,331	1,119	722.09	292.62
Total Debt	346.59	328.67	284.53	122.97	3.7	6.09
Net Cash (Debt)	865.81	980.05	741.12	759.43	501.99	152.84
Net Cash Growth	-21.53%	32.24%	-2.41%	51.28%	228.45%	-27.77%
Net Cash Per Share	4.75	5.57	4.66	5.39	4.25	1.53
Filing Date Shares Outstanding	183.45	181.91	165.07	154.23	133.01	100
Total Common Shares Outstanding	183.45	181.91	165.07	154.23	133.01	100
Working Capital	1,079	1,281	801.33	720.65	478.38	117.76
Book Value Per Share	6.08	6.88	4.51	4.97	4.49	1.51
Tangible Book Value	1,114	1,247	740.9	761.26	594.92	150.8
Tangible Book Value Per Share	6.07	6.86	4.49	4.94	4.47	1.51
Land	-	2.89	2.89	2.89	2.89	2.89
Buildings	-	65.54	45.08	16.01	11.21	10.07
Machinery	-	49.14	46.26	38.27	29.17	22.14
Construction In Progress	-	3.04	14.18	41.37	27.81	3.69
Leasehold Improvements	-	23.12	21.97	20.91	11.89	10.38

Source: S&P Capital IQ. Standard template. Financial Sources.